GDPUD assessing damage from the Mosquito Fire mtdemocrat.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mtdemocrat.com Daily Mail and Mail on Sunday newspapers.
German independent research institute BioMed X announces today the extension of its collaboration with Merck KGaA, Darmstadt, Germany, in the research project RNA Splicing in Cancer (RSC). As a result of the successful research work to date, Merck KGaA, Darmstadt, Germany has decided to acquire the IP rights in the .
BioMed X announces the extension of its collaboration with Merck in the research project RNA Splicing in Cancer. Merck has decided to acquire the IP rights in the project results and to continue the project for another year. The goal of the extension is to further validate novel potential drug targets based on these results.